Consumer Information for: APO-BOSENTAN
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
APO-BOSENTAN (bosentan) tablets are prescribed for the treatment of pulmonary arterial hypertension (high blood pressure in the blood vessels between the heart and the lungs).
What it does
APO-BOSENTAN reduces abnormally high blood pressure by relaxing these blood vessels. APOBOSENTAN tablets belong to the class of medicines known as endothelin receptor antagonists.
When it should not be used
Before you take APO-BOSENTAN:
Tests your doctor will do before treatment:- a blood test for liver function;
- a blood test for anemia (reduction in red blood cells);
- a pregnancy test.
Do not use APO-BOSENTAN if you:
- are hypersensitive (allergic) to bosentan or any other ingredients in the tablet (See What the important nonmedicinal ingredients are);
- have liver problems;
- are pregnant or planning to become pregnant (hormonal contraceptives alone are not effective when you take APO-BOSENTAN);
- are a woman of childbearing age and not using adequate contraceptive methods;
- are being treated with cyclosporine A, or glyburide.
Tell your doctor immediately if you are pregnant or plan to become pregnant in the near future. This is because APO-BOSENTAN may harm your unborn baby and you must not take APO-BOSENTAN if you are pregnant. You must also not become pregnant while taking APO-BOSENTAN. If you are a woman of childbearing age, your doctor or gynecologist will advise you about adequate contraceptive methods while taking APO-BOSENTAN. Because APOBOSENTAN may make hormonal contraception (e.g., oral, injection, implant or skin patches) ineffective, this method on its own is not reliable. Therefore, if you use hormonal contraceptives you must also use a barrier method (e.g., female condom, diaphragm, contraceptive sponge or your partner must also use a condom). Monthly pregnancy tests are recommended while you are taking APOBOSENTAN and you are of childbearing age.
Tell your doctor immediately if you are breastfeeding. You are advised to stop breastfeeding if APO-BOSENTAN is prescribed for you because it is not known if this drug passes into the milk in women who are taking APO-BOSENTAN.
If you are a man taking APO-BOSENTAN, it is possible that this medicine may lower your sperm count. It cannot be excluded that this may affect your ability to father a child. Talk to your doctor if you have any questions or concerns about this.
If you feel dizzy while taking APO-BOSENTAN, do not drive or operate any tools or machines.
APO-BOSENTAN is not recommended for children.
What the medicinal ingredient is
Bosentan monohydrate.
What the non-medicinal ingredients are
Colloidal silicon dioxide, crospovidone, magnesium stearate, methyl cellulose and poloxamer. The filmcoating is composed of hydroxypropyl methylcellulose, hydroxypropyl cellulose, polyethylene glycol, titanium Dioxide, euroxide red iron oxide and yellow iron oxide.
What dosage form it comes in
APO-BOSENTAN 62.5 mg is available as orangewhite
coloured, round-shaped biconvex film-coated
tablets engraved "APO" on one side and "62.5" on
the other side.
APO-BOSENTAN 125 mg is also available as
orange-white coloured, oval-shaped biconvex filmcoated
tablets engraved "APO" on one side and "125"
on the other side.
Warnings and precautions
Warnings and Precautions
Before you use APO-BOSENTAN talk to your doctor or
pharmacist if you are:
Before starting APO-BOSENTAN treatment, tell your doctor and your pharmacist if you are taking or have recently taken any other medicines, even those you have bought yourself. It is especially important to tell your doctor if you are taking:
- hormonal contraceptives (as these may not be effective as the sole method of contraception when you take APO-BOSENTAN);
- glyburide (for diabetes);
- cyclosporine A (a medicine used after transplants and to treat psoriasis), or any other drugs used to prevent rejection of transplanted organs;
- fluconazole (to treat fungal infections);
- rifampicin (to treat tuberculosis).
- vasodilators (drugs used to treat high blood pressure)
Tests during treatment:
Some patients taking bosentan were found to have
abnormal liver function values (increase in liver
enzymes) and some patients developed anemia
(reduction in red blood cells). Because these findings
may not cause symptoms you can feel or observe
yourself, your doctor will do regular blood tests to
assess any changes in your liver function and
hemoglobin level.
Liver function:
This blood test will be done:
- every month or more frequently, if needed.
If you develop abnormal liver function, your doctor may decide to reduce your dose or stop treatment with APO-BOSENTAN. When your blood test results for liver function return to normal, your doctor may decide to restart treatment with APOBOSENTAN.
Anemia:
This blood test will be done:
- after 1 month and after 3 months of treatment;
- every 3 months during treatment thereafter.
If you develop anemia, your doctor may decide to perform further tests to investigate the cause.
Your regular blood tests, both for liver function and anemia, are an important part of your treatment. We suggest you write in a diary the date of your most recent test and also that of your next test (ask your doctor for the date) to help you remember when your next test is due.
Pregnancy tests for women of childbearing age:
Due to the risk of failure of hormonal contraception
when taking APO-BOSENTAN and the risk in
patients with pulmonary hypertension of rapid and
severe deterioration of the disease, monthly
pregnancy tests are recommended before and during
treatment with APO-BOSENTAN.
Interactions with this medication
Drugs that may interact with APO-BOSENTAN include: warfarin, simvastatin and other statins, glyburide, ketoconazole, cyclosporine A, tacrolimus, sirolimus and hormonal contraceptives.
Proper use of this medication
Always take APO-BOSENTAN exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are unsure.
Usual Dose
The usual dose is one tablet, swallowed twice daily (morning and evening), consistently with or without food. Swallow the tablet with water. For the first 4 weeks, you will take a 62.5 mg tablet twice daily, from then on, your doctor will advise you to take a 125 mg tablet twice daily, depending on how you react to APO-BOSENTAN.
Overdose
If you take more tablets than you have been told to take, see a doctor or go to a hospital immediately.
Missed Dose
If you forget to take APO-BOSENTAN, take a dose as soon as you remember, then continue to take your tablets at the usual time. Do not take a double dose to make up for forgotten tablets.
Stopping treatment:
Suddenly stopping your treatment with APOBOSENTAN may lead to a worsening of your symptoms. Do not stop taking APO-BOSENTAN unless your doctor tells you to. Your doctor may tell you to reduce the dose over a few days before stopping completely.
Side effects and what to do about them
Like all medicines, APO-BOSENTAN can have side effects even when used as directed.
If you notice yellowing of the skin or eyes (jaundice) or other symptoms such as nausea, vomiting, fever, abdominal pain or unusual tiredness, see your doctor immediately because this may be related to abnormal liver function.
Headaches were the most common side effect in clinical studies.
You may also notice one or more of the following side effects
- flushed appearance, inflammation of the throat and nasal passages, swelling of the legs and ankles, or other signs of fluid retention, low blood pressure, irregular heartbeat, heartburn, tiredness, itching, nasal congestion, nausea. If these side effects become bothersome, contact your doctor.
Other less common side effects that you might notice:
- vomiting, abdominal pain, diarrhea, skin rash.
If you notice any other side effects or signs of allergic reaction (e.g. swelling of the face or tongue, rash, pruritus) while you are taking APOBOSENTAN or if any of the side effects mentioned above worries you, please inform your doctor or pharmacist.
Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drugs and seek immediate emergency medical attention |
---|---|---|---|
Common | |||
Abdominal pain | ✔ | ||
Itching | ✔ | ||
Nausea | ✔ | ||
Other signs of fluid retention | ✔ | ||
Swelling of the legs and ankles | ✔ | ||
Tiredness | ✔ | ||
Vomiting | ✔ | ||
Uncommon | |||
Rash | ✔ | ||
Swelling of the face, throat or tongue | ✔ | ||
Rare | |||
Asthma like symptoms (wheezing) | ✔ | ||
Yellowing of the skin and eyes (jaundice) | ✔ Call your doctor immediately |
This is not a complete list of side effects. For any unexpected effects while taking APO-BOSENTAN, contact your doctor or pharmacist.
How to store
Keep out of reach and sight of children. Store at room temperature 15 °C to 30 ºC. Do not use after the expiry date stated on the blister or bottles.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
If you want more information about APOBOSENTAN:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this patient medication information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website http://www.apotex.ca/products, or by calling 1-800-667-4708.
This leaflet was prepared by Apotex Inc., Toronto, Ontario, M9L 1T9.
Date of revision: October 23, 2018
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
TEVA-LACOSAMIDE | 02472929 | TEVA CANADA LIMITED | LACOSAMIDE 150 MG |
TEVA-LACOSAMIDE | 02472910 | TEVA CANADA LIMITED | LACOSAMIDE 100 MG |
TEVA-LACOSAMIDE | 02472902 | TEVA CANADA LIMITED | LACOSAMIDE 50 MG |
TEVA-LACOSAMIDE | 02472937 | TEVA CANADA LIMITED | LACOSAMIDE 200 MG |